Navigation Links
Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
Date:9/23/2013

NEW YORK, Sept. 23, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), one of the world's top 20 leading pharmaceutical companies today announced its collaboration with Univision Communications Inc. to launch its first integrated campaign for U.S. Hispanics. Leveraging Univision Network's record-breaking variety show "Sabado Gigante" (Giant Saturday), the collaboration will help Boehringer Ingelheim Pharmaceuticals, Inc. bring more health education to more people as the exclusive sponsor of the program's popular segment "Ritmo Dieta," a family-friendly dance competition where contestants demonstrate their best moves in efforts to lose weight and live healthier lives. The collaboration will become an extension of the Network's Salud Es Vida (Health is Life) health platform, aimed at raising awareness, increasing knowledge and encouraging positive health decision-making among the U.S. Hispanic community.

"Boehringer Ingelheim's strategic collaboration with Univision is another testament to our ongoing commitment to connect and engage with U.S. Hispanics. We aim to educate this burgeoning community on diabetes and healthy living alternatives, including dance, healthy eating and fitness," said Christopher Kaplan, senior vice president and chief marketing officer, Boehringer Ingelheim Pharmaceuticals, Inc. "This collaboration involving 'Sabado Gigante,' allows us to be welcomed into the homes of millions of Latino families who have made watching Don Francisco's iconic show a tradition."

"Ritmo Dieta" will feature a 13-week competition, showcasing 10 contestants who will vie for a chance to win the grand prize. One of the contestants has been diagnosed with type 2 diabetes. Viewers can join the conversation regarding Salud es Vida on Twitter via @Univision and #SaludesVida as well as share their comments on Facebook.com/Univ
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
2. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
3. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
4. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
5. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
6. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
7. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
8. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
9. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
11. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  HeartIT is ... the first Cardiac Magnetic Resonance Solution in the ... within a standard web browser. Precession™ combines zero ... features unmatched in the industry. This provides CMR ... all the critical functions of a successful CMR ...
(Date:3/3/2015)... NEWARK, Calif. , March 3, 2015 Depomed, ... will be presenting at the 27 th Annual Roth ... presentation is scheduled for 12:30 pm ET (9:30 am PT) ... webcast, and the webcast can be accessed via the Investor ... A recording of the webcast will be archived for 30 ...
(Date:3/3/2015)... March 3, 2015  MabVax Therapeutics (OTCQB: MBVX), a cancer ... , the Company,s President and CEO, will be presenting at ... March 9 – 12, 2015 at the Ritz Carlton in ... MabVax,s presentation is scheduled for Wednesday, March 11 th , ... for review on the Investor Relations section of the Company,s ...
Breaking Medicine Technology:Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2Depomed To Present At 27th Annual Roth Conference 2
... 25 BiPar Sciences, Inc., a,privately held biopharmaceutical ... has hired industry veterans Eric D. Malek as ... as vice president,for regulatory affairs. "Over the ... role in clinical,stage product partnerships involving major pharmaceutical ...
... ARBOR, Mich. Sept. 24 Velcura Therapeutics, Inc., ... with the,U.S. Food and Drug Administration (FDA) Sept. ... of VEL-0230, a drug developed to treat bone,disease. ... (IND),meeting was to obtain feedback from the FDA,s ...
Cached Medicine Technology:BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 2Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 3
(Date:3/3/2015)... Mansfield, Texas (PRWEB) March 03, 2015 ... natural childbirth, announced today they now have over 130 ... Canada and 1 in Germany. In addition, the company ... joining their existing childbirth educator certification program . ... both mom and her birth partner. The practical information ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 March 3, ... for the 200th episode. The episode was a unique one, ... fourth season, but because it featured two men who were ... car accident. At the beginning of the episode, Deierlein said ... times on my radio show, but I’m very excited that ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
(Date:3/3/2015)... 2015 Venato, a secure cloud-based ... their flagship software solution now provides an automated ... uploaded to the National Healthcare Safety Network (NHSN). ... (CMS) require that hospitals submit healthcare personnel (HCP) ... than May 15 for each influenza season in ...
(Date:3/3/2015)... Chicago has long been known as a premier ... a level of basketball to Chicago that the world had ... his Chicago Bulls days in the 1990’s. His brilliance created ... This era also witnessed the birth and rise of Nike ... rich basketball culture, US Sports Camps seeks to meet an ...
Breaking Medicine News(10 mins):Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2
... trouble finding that perfect,holiday gift? Maybe it,s time ... a healthier smile. , , ... , , Registered ... free and unrestricted use at http://www.mediaseed.tv . , ...
... China,s leading,research, consulting and IT outsourcing service provider, and ... Kong Stock Exchange:,HK08235), recently released its article on China,s ... In 2007, the rapid development of the ... in turn drove the development of medical insurance,policies. Benefiting ...
... Serving as a model for public health action on vitamin D, GrassrootsHealth, ... scientists, institutions and individuals committed to solving the worldwide vitamin D deficiency ... for health professionals at UC San Diego, December 2 from 8 a.m. ... ...
... other household members may be the most effective way of ... say a group of paediatric intensive care doctors on ... infectious disease which affects infants and young children. Vaccination is ... four months of age, with a further booster after three ...
... the presence of disinfecting solutions , , THURSDAY, Nov. 27 (HealthDay ... say Israeli researchers who found at least one pathogen in ... The tests of contact lens disinfection solution in the storage ... of severe corneal infections -- was the most common type ...
... from end-stage renal disease (ESRD), a growing number of ... (CHUM), have become the beneficiaries of a North American ... blood purification technique, HDF is indicated for ESRD patients. ... section, preliminary results show a clear advantage of high ...
Cached Medicine News:Health News:CCID Consulting Discusses China's Medical Equipment Market 2Health News:CCID Consulting Discusses China's Medical Equipment Market 3Health News:CCID Consulting Discusses China's Medical Equipment Market 4Health News:CCID Consulting Discusses China's Medical Equipment Market 5Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 2Health News:Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis 3Health News:Parents of new babies should be considered for a whooping cough booster, say experts 2Health News:Contact Lens Cases Often Contaminated 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: